IFN-γ can promote tumor growth by downregulation of MHC molecules, promoting angiogenesis and eliciting the expression of tolerant molecules such as IDO and checkpoint inhibitors like PD-L1 and TIM3 [62]. This evidence concerns the gene HAVCR2 and neoplasm.